Jump to main content
Jump to site search

Issue 39, 2014
Previous Article Next Article

Exploring functional cyclophellitol analogues as human retaining beta-glucosidase inhibitors

Author affiliations

Abstract

The natural product, cyclophellitol and its aziridine analogue are potent mechanism-based retaining β-glucosidase inhibitors. In this paper we explore the inhibitory potency of a number of cyclophellitol analogues against the three human retaining β-glucosidases, GBA, GBA2 and GBA3. We demonstrate that N-alkyl cyclophellitol aziridine is at least equally potent in inhibiting the enzymes evaluated as its N-acyl congener, whereas the N-sulfonyl analogue is a considerably weaker inhibitor. Our results complement the literature on the inhibitory potency of cyclophellitol analogues and hold promise for the future design of more effective activity-based retaining glycosidase probes with respect to probe stability in physiological media.

Graphical abstract: Exploring functional cyclophellitol analogues as human retaining beta-glucosidase inhibitors

Back to tab navigation
Please wait while Download options loads

Publication details

The article was received on 29 Jul 2014, accepted on 19 Aug 2014 and first published on 19 Aug 2014


Article type: Paper
DOI: 10.1039/C4OB01611D
Citation: Org. Biomol. Chem., 2014,12, 7786-7791
  •   Request permissions

    Exploring functional cyclophellitol analogues as human retaining beta-glucosidase inhibitors

    K. Li, J. Jiang, M. D. Witte, W. W. Kallemeijn, W. E. Donker-Koopman, R. G. Boot, J. M. F. G. Aerts, J. D. C. Codée, G. A. van der Marel and H. S. Overkleeft, Org. Biomol. Chem., 2014, 12, 7786
    DOI: 10.1039/C4OB01611D

Search articles by author